サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1392303

Organ-on-a-chipの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年の予測

Global Organ On A Chip Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日: | 発行: Value Market Research | ページ情報: 英文 241 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.36円
Organ-on-a-chipの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年の予測
出版日: 2023年11月01日
発行: Value Market Research
ページ情報: 英文 241 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Organ-on-a-chip市場の世界需要は、2022年の8,845万米ドルから2030年には10億4,983万米ドル近くの市場規模に達すると推定され、調査期間2023～2030年のCAGRは36.24%です。

Organ-on-a-chipは、人間の臓器の構造と機能を模倣できるマイクロ流体細胞培養装置です。特定の臓器の生理学的・機械的側面を再現することで、従来の細胞培養法と比較して、より正確でダイナミックなヒト生物学の表現を提供することを目的としています。各装置は、特定の臓器や組織の微小環境や細胞間相互作用をシミュレートするように設計されています。

市場力学：

Organ-on-a-chip市場は、生物医学研究や医薬品開発における変革の可能性により急速に拡大しています。この技術は、臓器や組織をよりヒトに近い形で表現することで、従来のモデルの限界に対処するものです。この技術は、動物実験に代わる人道的な代替手段を提供し、倫理的な懸念と規制圧力の高まりに合致しています。Organ-on-a-chipプラットフォームがヒトの生物学を正確に模倣できることは、薬剤開発にとって大きな意味を持ち、薬剤の有効性と安全性の予測を強化します。さらに、これらのモデルは、治療に対する個々の反応の研究を可能にすることで、個別化医療の進展をサポートします。同市場は、政府、研究機関、製薬会社による投資、共同研究の促進、技術の進歩によってさらに牽引されています。微細加工技術の継続的な向上は、Organ-on-a-chipシステムの拡大性と複雑性に寄与しています。慢性疾患の増加に伴い、規制当局によるOrgan-on-a-chipモデルの検証は、医療と研究手法に革命をもたらす可能性を強調しています。パートナーシップが盛んになり、受容が拡大するにつれて、Organ-on-a-chip技術は生物医学研究と治療開発を再構築する上で極めて重要な役割を果たすようになります。

この調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、Organ-on-a-chipの世界市場における各セグメントを包括的に評価することもできます。Organ-on-a-chip産業の成長と動向は、この調査に全体的なアプローチを提供します。

地域分析：

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカのOrgan-on-a-chip市場の現在と将来の需要を強調する地域展望をカバーしています。さらに、著名な全地域における個々の用途セグメントの需要・推定・予測にも焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 Organ-on-a-chip-産業分析

  • イントロダクション：市場力学
  • 市場の促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 Organ-on-a-chipの世界市場分析：製品・サービス別

  • 製品・サービス別概要
  • 実績データと予測データ
  • 製品・サービス別分析
  • 製品
  • 機器
  • Organ-on-a-chipデバイス（肝臓オンチップ、肺オンチップ、腸オンチップ、腎臓オンチップ、心臓オンチップ、その他）
  • サービス

第6章 Organ-on-a-chipの世界市場分析：用途別

  • 用途別概要
  • 実績データと予測データ
  • 用途別分析
  • 創薬
  • トキシコロジー調査
  • その他

第7章 Organ-on-a-chipの世界市場分析：最終用途別

  • 最終用途別概要
  • 実績データと予測データ
  • 最終用途別分析
  • 学術・研究機関
  • 製薬・バイオテクノロジー企業
  • その他

第8章 Organ-on-a-chipの世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東とアフリカ

第9章 Organ-on-a-chip企業の競合情勢

  • Organ-on-a-chip市場の競合
  • 提携・協力・合意
  • 合併・買収
  • 新製品の発売
  • その他の開発

第10章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • Emulate Inc.
  • MIMETAS B.V.
  • Valo Health
  • Nortis Inc.
  • AxoSim
  • BICO-THE BIO CONVERGENCE COMPANY
  • CN Bio Innovations Ltd
  • SynVivo Inc.
  • The Charles Stark Draper Laboratory Inc.
  • AlveoliX AG
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product & Service (USD MN)
  • Products Market Sales by Geography (USD MN)
  • Instruments Market Sales by Geography (USD MN)
  • Organ-on-a-Chip Devices (Liver-on-a-Chip, Lung-on-a-Chip, Intestine-on-a-Chip, Kidney-on-a-Chip, Heart-on-a-Chip, Others) Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Analysis Market by Application (USD MN)
  • Drug Discovery Market Sales by Geography (USD MN)
  • Toxicology Research Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by End-use (USD MN)
  • Academic and Research Institutes Market Sales by Geography (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Organ On A Chip Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Organ On A Chip Report
  • Market Research Process
  • Market Research Methodology
  • Global Organ On A Chip Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product & Service
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End-use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product & Service (USD MN)
  • Products Market Sales by Geography (USD MN)
  • Instruments Market Sales by Geography (USD MN)
  • Organ-on-a-Chip Devices (Liver-on-a-Chip, Lung-on-a-Chip, Intestine-on-a-Chip, Kidney-on-a-Chip, Heart-on-a-Chip, Others) Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Drug Discovery Market Sales by Geography (USD MN)
  • Toxicology Research Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by End-use (USD MN)
  • Academic and Research Institutes Market Sales by Geography (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112112788

The global demand for Organ On A Chip Market is presumed to reach the market size of nearly USD 1049.83 MN by 2030 from USD 88.45 MN in 2022 with a CAGR of 36.24% under the study period 2023 - 2030.

An Organ-on-a-Chip (OOC) is a microfluidic cell culture device that is able to mimic the structure and function of human organs. It aims to replicate the physiological and mechanical aspects of specific organs to provide a more accurate and dynamic representation of human biology compared to traditional cell culture methods. Each device is designed to simulate the microenvironment and cellular interactions of a particular organ or tissue.

MARKET DYNAMICS:

The organ-on-a-chip market is expanding rapidly due to its transformative potential in biomedical research and drug development. This technology addresses the limitations of traditional models by providing more human-relevant representations of organs and tissues. It offers a humane alternative to animal testing, aligning with increasing ethical concerns and regulatory pressures. The ability of OOC platforms to mimic human biology accurately has profound implications for drug development, enhancing predictions of drug efficacy and safety. Moreover, these models support the advancement of personalized medicine by allowing the study of individual responses to treatments. The market is further driven by investments from governments, research institutions, and pharmaceutical companies, fostering collaborations and technological advancements. Ongoing improvements in microfabrication technology contribute to the scalability and complexity of OOC systems. With rising chronic diseases, the validation of OOC models by regulatory authorities underscores their potential to revolutionize healthcare and research practices. As partnerships flourish and acceptance grows, Organ-on-a-Chip technology is poised to play a pivotal role in reshaping biomedical research and therapeutic development.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of organ on a chip. The growth and trends of organ on a chip industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the organ on a chip market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product & Service

  • Products
  • Instruments
  • Organ-On-A-Chip Devices (Liver-On-A-Chip, Lung-On-A-Chip, Intestine-On-A-Chip, Kidney-On-A-Chip, Heart-On-A-Chip, Others)
  • Services

By Application

  • Drug Discovery
  • Toxicology Research
  • Others

By End-Use

  • Academic And Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Organ On A Chip market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Organ On A Chip market include Emulate, Inc., MIMETAS B.V., Valo Health, Nortis, Inc., AxoSim, BICO - THE BIO CONVERGENCE COMPANY, CN Bio Innovations Ltd, SynVivo, Inc., The Charles Stark Draper Laboratory, Inc., AlveoliX AG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . ORGAN ON A CHIP - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product & Service
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End-use
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL ORGAN ON A CHIP MARKET ANALYSIS BY PRODUCT & SERVICE

  • 5.1 Overview by Product & Service
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Product & Service
  • 5.4 Products Historic and Forecast Sales by Regions
  • 5.5 Instruments Historic and Forecast Sales by Regions
  • 5.6 Organ-on-a-Chip Devices (Liver-on-a-Chip, Lung-on-a-Chip, Intestine-on-a-Chip, Kidney-on-a-Chip, Heart-on-a-Chip, Others) Historic and Forecast Sales by Regions
  • 5.7 Services Historic and Forecast Sales by Regions

6 . GLOBAL ORGAN ON A CHIP MARKET ANALYSIS BY APPLICATION

  • 6.1 Overview by Application
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Application
  • 6.4 Drug Discovery Historic and Forecast Sales by Regions
  • 6.5 Toxicology Research Historic and Forecast Sales by Regions
  • 6.6 Others Historic and Forecast Sales by Regions

7 . GLOBAL ORGAN ON A CHIP MARKET ANALYSIS BY END-USE

  • 7.1 Overview by End-use
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by End-use
  • 7.4 Academic and Research Institutes Historic and Forecast Sales by Regions
  • 7.5 Pharmaceutical & Biotechnology Companies Historic and Forecast Sales by Regions
  • 7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL ORGAN ON A CHIP MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2. North America By Segment Sales Analysis
    • 8.3.3. North America By Country Sales Analysis
    • 8.3.4. United State Sales Analysis
    • 8.3.5. Canada Sales Analysis
    • 8.3.6. Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2. Europe by Segment Sales Analysis
    • 8.4.3. Europe by Country Sales Analysis
    • 8.4.4. United Kingdom Sales Analysis
    • 8.4.5. France Sales Analysis
    • 8.4.6. Germany Sales Analysis
    • 8.4.7. Italy Sales Analysis
    • 8.4.8. Russia Sales Analysis
    • 8.4.9. Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2. Asia Pacific by Segment Sales Analysis
    • 8.5.3. Asia Pacific by Country Sales Analysis
    • 8.5.4. China Sales Analysis
    • 8.5.5. India Sales Analysis
    • 8.5.6. Japan Sales Analysis
    • 8.5.7. South Korea Sales Analysis
    • 8.5.8. Australia Sales Analysis
    • 8.5.9. South East Asia Sales Analysis
    • 8.5.10. Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2. Latin America by Segment Sales Analysis
    • 8.6.3. Latin America by Country Sales Analysis
    • 8.6.4. Brazil Sales Analysis
    • 8.6.5. Argentina Sales Analysis
    • 8.6.6. Peru Sales Analysis
    • 8.6.7. Chile Sales Analysis
    • 8.6.8. Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2. Middle East & Africa by Segment Sales Analysis
    • 8.7.3. Middle East & Africa by Country Sales Analysis
    • 8.7.4. Saudi Arabia Sales Analysis
    • 8.7.5. UAE Sales Analysis
    • 8.7.6. Israel Sales Analysis
    • 8.7.7. South Africa Sales Analysis
    • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE ORGAN ON A CHIP COMPANIES

  • 9.1. Organ On A Chip Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF ORGAN ON A CHIP INDUSTRY

  • 10.1. Company Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Emulate Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Company Revenue
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. MIMETAS B.V.
    • 10.4.1. Company Overview
    • 10.4.2. Company Revenue
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Valo Health
    • 10.5.1. Company Overview
    • 10.5.2. Company Revenue
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. Nortis Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Company Revenue
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. AxoSim
    • 10.7.1. Company Overview
    • 10.7.2. Company Revenue
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. BICO - THE BIO CONVERGENCE COMPANY
    • 10.8.1. Company Overview
    • 10.8.2. Company Revenue
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. CN Bio Innovations Ltd
    • 10.9.1. Company Overview
    • 10.9.2. Company Revenue
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. SynVivo Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Company Revenue
    • 10.10.3. Products
    • 10.10.4. Recent Developments
  • 10.11. The Charles Stark Draper Laboratory Inc.
    • 10.11.1. Company Overview
    • 10.11.2. Company Revenue
    • 10.11.3. Products
    • 10.11.4. Recent Developments
  • 10.12. AlveoliX AG
    • 10.12.1. Company Overview
    • 10.12.2. Company Revenue
    • 10.12.3. Products
    • 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies